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Background:  Preclinical Diastolic Dysfunction (PDD) has been broadly defined as subjects with left ventricular diastolic dysfunction, without 
the diagnosis of congestive heart failure (HF), and with normal systolic function. Renal function is an important prognostic marker in patients with 
symptomatic HF. However, the prognostic value of renal function in PDD remains poorly defined. Our objective was to determine the risk factors 
associated with the progression from PDD to symptomatic HF.
Methods:  Using the resources of the Rochester Epidemiology Project, all residents of Olmsted County, MN who underwent echocardiography 
between 1/1/2004 and 12/31/2005 and had Grade 2-4 diastolic dysfunction (DD) and EF ≥ 50% were identified. Patients with a diagnosis of HF 
or atrial fibrillation prior to and within 30 days of the echocardiogram were excluded.
Results:  A total of 388 patients met the inclusion criteria. The mean age of the cohort was 67 ± 12 years with a female (57%) predominance. 
Prevalence of renal insufficiency (estimated GFR <60ml/min/1.73 m2) was 34%. The 3-year cumulative probabilities of development of (Stage 
C) HF, cardiac hospitalization, development of atrial fibrillation, and mortality were 11.6%, 6.2%, 14.5%, and 10.1% respectively. Using Cox’s 
proportional hazard modeling we determined that for every 1 unit increase in the plasma Creatinine, the hazard of developing HF increases by 26% 
(HR=1.26, 95% CI=1.08-1.47; p=0.0039). In multivariable Cox’s proportional hazard regression analysis we determined that renal dysfunction was 
associated with the subsequent development of HF after adjustment for age, sex, body mass index, hypertension, coronary disease, ejection fraction, 
left atrial volume, and deceleration time (HR=2.0, 95% CI=1.1-3.6; p=0.019).
Conclusion: This population-based study demonstrated that in PDD, there was a moderate degree of progression to development of HF over 3 
years and renal dysfunction was associated with increased risk of progression to symptomatic HF.
